NEW YORK, July 19 (GenomeWeb News) - Sigma-Aldrich has licensed a number of RNA interference patents known as the Kreutzer-Limmer patent family from Alnylam Pharmaceuticals to provide research products and services, the companies said today.

 

The patents cover short interfering RNAs and their use to mediate RNA interference in mammalian cells.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.